Charles Newton/Lancet Neurol
Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa.Ba-Diop A
Marin B
Druet-Cabanac M
Ngoungou EB
Newton CR
Preux PM
Lancet Neurol, (2014). 13:1029-44
Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies.Ngugi AK
Bottomley C
Kleinschmidt I
Wagner RG
Kakooza-Mwesige A
Ae-Ngibise K
Owusu-Agyei S
Masanja H
Kamuyu G
Odhiambo R
Chengo E
Sander JW
Newton CR
Seeds group
Lancet Neurol, (2013). 12:253-63
Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study.Mbuba CK
Ngugi AK
Fegan G
Ibinda F
Muchohi SN
Nyundo C
Odhiambo R
Edwards T
Odermatt P
Carter JA
Newton CR
Lancet Neurol, (2012). 11:688-96
Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study.Sadarangani M
Seaton C
Scott JA
Ogutu B
Edwards T
Prins A
Gatakaa H
Idro R
Berkley JA
Peshu N
Neville BG
Newton CR
Lancet Neurol, (2008). 7:145-50
Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors.Edwards T
Scott AG
Munyoki G
Odera VM
Chengo E
Bauni E
Kwasa T
Sander LW
Neville BG
Newton CR
Lancet Neurol, (2008). 7:50-6
Pathogenesis, clinical features, and neurological outcome of cerebral malaria.Idro R
Jenkins NE
Newton CR
Lancet Neurol, (2005). 4:827-40
